Drug Profile
Research programme: cancer vaccines - Spotlight Innovation
Alternative Names: Immunoplex™ Breast Cancer Immunotherapy; Immunoplex™ Melanoma Immunotherapy; Immunoplex™ Prostate Cancer ImmunotherapyLatest Information Update: 12 Oct 2016
Price :
$50
*
At a glance
- Originator Memcine Pharmaceuticals
- Developer Spotlight Innovation
- Class Cancer vaccines; Peptide vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer; Malignant melanoma; Prostate cancer